Dilated Cardiomyopathy: A Comprehensive Approach to Diagnosis and Risk Stratification
暂无分享,去创建一个
P. Cunha | A. Lousinha | Mário Oliveira | R. Ferreira | S. A. Rosa | D. Antunes | T. Pereira-da-Silva | M. Antunes | V. Ferreira | André Ferreira | A. Ferreira
[1] L. Mestroni,et al. Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy , 2022, Journal of the American College of Cardiology.
[2] P. Lambiase,et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. , 2022, European heart journal.
[3] D. Corrado,et al. Cardiac magnetic resonance imaging of arrhythmogenic cardiomyopathy: evolving diagnostic perspectives , 2022, European Radiology.
[4] E. Ashley,et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases , 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[5] H. Pak,et al. Prognostic Cardiac Magnetic Resonance Markers of Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy for Predicting Heart Failure Outcomes , 2022, Journal of the American Heart Association.
[6] Christos G Mihos,et al. Cardiac geometry, function and mechanics in left ventricular non-compaction cardiomyopathy with preserved ejection fraction , 2022, Journal of Echocardiography.
[7] G. Abela,et al. Ventricular non-compaction review , 2021, Heart Failure Reviews.
[8] M. Dorobanțu,et al. The prognostic value of right ventricular longitudinal strain and 3D ejection fraction in patients with dilated cardiomyopathy , 2021, The International Journal of Cardiovascular Imaging.
[9] S. Kazama,et al. A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy , 2021, ESC heart failure.
[10] S. Heymans,et al. Implications of Genetic Testing in Dilated Cardiomyopathy , 2020, Circulation. Genomic and precision medicine.
[11] A. Mazzanti,et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. , 2020, International journal of cardiology.
[12] James A. White,et al. Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy , 2020, Circulation. Cardiovascular imaging.
[13] D. Corrado,et al. Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy , 2020, Journal of the American Heart Association.
[14] G. Efthimiadis,et al. Emerging concepts in arrhythmogenic dilated cardiomyopathy , 2020, Heart Failure Reviews.
[15] S. Heymans,et al. Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction , 2020, Heart.
[16] S. Goland,et al. Peripartum Cardiomyopathy: JACC State-of-the-Art Review. , 2020, Journal of the American College of Cardiology.
[17] J. Svendsen,et al. Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure-DANISH-MRI. , 2019, American heart journal.
[18] J. Seidman,et al. Precision Medicine in the Management of Dilated Cardiomyopathy: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.
[19] V. Carriel,et al. Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype-phenotype correlation study. , 2019, European heart journal cardiovascular Imaging.
[20] M. Link,et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. , 2019, Heart rhythm.
[21] M. Link,et al. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis , 2019, European heart journal.
[22] Y. Pinto,et al. Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging. , 2019, European heart journal cardiovascular Imaging.
[23] L. Mestroni,et al. Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy. , 2019, Journal of the American College of Cardiology.
[24] R. Porcher,et al. Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies. , 2019, Circulation.
[25] P. Elliott,et al. Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study. , 2019, European heart journal cardiovascular Imaging.
[26] E. Behr,et al. Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy , 2019, Circulation.
[27] L. Steinmetz,et al. Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy , 2019, Circulation. Heart failure.
[28] T. Marwick,et al. Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar , 2018, European heart journal.
[29] Dudley J Pennell,et al. Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement , 2019, JACC. Cardiovascular imaging.
[30] R. Blankstein,et al. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy. , 2019, JACC. Cardiovascular imaging.
[31] R. Kim,et al. Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement. , 2018, JACC. Cardiovascular imaging.
[32] I. van der Made,et al. RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling , 2018, Circulation.
[33] J. Cornel,et al. The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis. , 2018, JACC. Cardiovascular imaging.
[34] Susanna Price,et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. , 2018, European heart journal.
[35] G. Barbati,et al. Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathy. , 2018, The American journal of cardiology.
[36] S. Heymans,et al. Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology , 2018, Cardiovascular research.
[37] D. Judge,et al. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) , 2018, Genetics in Medicine.
[38] R. Płoski,et al. Rapid and effective response of the R222Q SCN5A to quinidine treatment in a patient with Purkinje-related ventricular arrhythmia and familial dilated cardiomyopathy: a case report , 2018, BMC Medical Genetics.
[39] D. Pennell,et al. Sex‐ and age‐based differences in the natural history and outcome of dilated cardiomyopathy , 2018, European journal of heart failure.
[40] D. O’Regan,et al. Genetic Etiology for Alcohol-Induced Cardiac Toxicity , 2018, Journal of the American College of Cardiology.
[41] A. Wilde,et al. Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy. , 2018, JACC. Clinical electrophysiology.
[42] N. Yamada,et al. Mortality and Sudden Cardiac Death Risk Stratification Using the Noninvasive Combination of Wide QRS Duration and Late Gadolinium Enhancement in Idiopathic Dilated Cardiomyopathy , 2018, Circulation. Arrhythmia and electrophysiology.
[43] S. Heymans,et al. Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias , 2018, European heart journal.
[44] Kenneth L. Jones,et al. Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures , 2018, JACC. Clinical electrophysiology.
[45] P. Elliott,et al. Evolving concepts in dilated cardiomyopathy , 2018, European journal of heart failure.
[46] H. Aburatani,et al. Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling , 2018, Scientific Reports.
[47] M. Emdin,et al. Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy. , 2018, International journal of cardiology.
[48] P. Schwartz,et al. Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation. , 2017, International journal of cardiology.
[49] J. McMurray,et al. Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis , 2017, Heart.
[50] Amit R. Patel,et al. Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy. , 2017, JACC. Cardiovascular imaging.
[51] D. Judge,et al. Arrhythmogenic cardiomyopathy: pathology, genetics, and concepts in pathogenesis , 2017, Cardiovascular research.
[52] D. Pennell,et al. Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction , 2017 .
[53] Jeroen J. Bax,et al. Relation of Myocardial Contrast-Enhanced T1 Mapping by Cardiac Magnetic Resonance to Left Ventricular Reverse Remodeling After Cardiac Resynchronization Therapy in Patients With Nonischemic Cardiomyopathy. , 2017, The American journal of cardiology.
[54] Y. Pinto,et al. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy , 2017, European journal of heart failure.
[55] James A. White,et al. Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. , 2017, JACC. Heart failure.
[56] L. Calò,et al. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. , 2016, Journal of the American College of Cardiology.
[57] W. Stevenson,et al. Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers. , 2016, Journal of the American College of Cardiology.
[58] Eugenio Picano,et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. , 2016, European heart journal cardiovascular Imaging.
[59] Hans Eiskjær,et al. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. , 2016, The New England journal of medicine.
[60] L. Lund,et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[61] L. Khachatryan,et al. Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy , 2016, Inflammation Research.
[62] S. Cook,et al. The Diagnosis and Evaluation of Dilated Cardiomyopathy. , 2016, Journal of the American College of Cardiology.
[63] S. Heymans,et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. , 2016, European heart journal.
[64] C. Selton-Suty,et al. Right ventricular dysfunction in patients with idiopathic dilated cardiomyopathy: Prognostic value and predictive factors. , 2016, Archives of cardiovascular diseases.
[65] Andrea Mazzanti,et al. 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.
[66] E. Nagel,et al. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. , 2016, JACC. Cardiovascular imaging.
[67] T. Biering-Sørensen,et al. Global Longitudinal Strain Is a Superior Predictor of All-Cause Mortality in Heart Failure With Reduced Ejection Fraction. , 2015, JACC. Cardiovascular imaging.
[68] L. Mestroni,et al. Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life‐Threatening Arrhythmias , 2015, Journal of the American Heart Association.
[69] Reza Razavi,et al. Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators. , 2015, Heart rhythm.
[70] G. Korosoglou,et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. , 2015, European heart journal cardiovascular Imaging.
[71] A. di Lenarda,et al. Persistent Recovery of Normal Left Ventricular Function and Dimension in Idiopathic Dilated Cardiomyopathy During Long‐Term Follow‐up: Does Real Healing Exist? , 2015, Journal of the American Heart Association.
[72] Karen S. Frese,et al. Atlas of the clinical genetics of human dilated cardiomyopathy. , 2014, European heart journal.
[73] L. Monserrat,et al. Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[74] A. Kadish,et al. Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. , 2014, Journal of the American College of Cardiology.
[75] T. Edvardsen,et al. Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[76] R. Hauer,et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers. , 2013, The American journal of cardiology.
[77] D. Hedges,et al. Dilated cardiomyopathy: the complexity of a diverse genetic architecture , 2013, Nature Reviews Cardiology.
[78] W. Stevenson,et al. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. , 2013, JACC. Cardiovascular imaging.
[79] Y. Pinto,et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.
[80] Tevfik F Ismail,et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.
[81] R. Hauer,et al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy , 2012, European journal of heart failure.
[82] Yves Coudière,et al. Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy. , 2012, Journal of the American College of Cardiology.
[83] L. Mestroni,et al. Truncations of titin causing dilated cardiomyopathy. , 2012, The New England journal of medicine.
[84] Mike Kirby,et al. ESC Guidelines on the Management of Cardiovascular Diseases During Pregnancy , 2012 .
[85] Marco Merlo,et al. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. , 2011, Journal of the American College of Cardiology.
[86] M. Vorgerd,et al. De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy. , 2010, Human molecular genetics.
[87] E. Donal,et al. Global longitudinal strain as a major predictor of cardiac events in patients with depressed left ventricular function: a multicenter study. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[88] B. Popescu,et al. Left ventricular remodelling and torsional dynamics in dilated cardiomyopathy: reversed apical rotation as a marker of disease severity , 2009, European journal of heart failure.
[89] A. Moss,et al. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. , 2006, Journal of the American College of Cardiology.
[90] T. Marwick,et al. Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. , 2004, Journal of the American College of Cardiology.
[91] Hugh Calkins,et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.
[92] W. Grimm,et al. Noninvasive Arrhythmia Risk Stratification in Idiopathic Dilated Cardiomyopathy: Results of the Marburg Cardiomyopathy Study , 2003, Circulation.